UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1943-01-01
- Employees
- 8.1K
- Market Cap
- -
Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon
- Conditions
- Major Depressive DisorderInsomnia
- Interventions
- First Posted Date
- 2008-03-25
- Last Posted Date
- 2019-07-26
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 29
- Registration Number
- NCT00642694
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer
- Conditions
- Central Venous CathetersCatheter-related OcclusionDeep Vein ThrombosisChildhood CancerCatheter-related Infection
- Interventions
- First Posted Date
- 2008-03-11
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 136
- Registration Number
- NCT00633061
- Locations
- 🇺🇸
Children's Medical Center, Dallas, Texas, United States
Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation
- Conditions
- Cardiac ArrestCardiopulmonary Arrest
- Interventions
- First Posted Date
- 2008-03-05
- Last Posted Date
- 2019-09-17
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 130
- Registration Number
- NCT00628550
- Locations
- 🇺🇸
Universtity of Texas Southwestern, Children's Medical Center, Dallas, Texas, United States
Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation
- First Posted Date
- 2008-03-05
- Last Posted Date
- 2020-09-25
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 119
- Registration Number
- NCT00628394
- Locations
- 🇺🇸
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics
- First Posted Date
- 2008-03-05
- Last Posted Date
- 2011-06-28
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT00628420
- Locations
- 🇺🇸
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸Veteran's Affairs Medical Center, Dallas, Texas, United States
Pharmacokinetics of Linezolid in Children With Cystic Fibrosis
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2020-03-27
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT00625703
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer
- First Posted Date
- 2008-02-25
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT00622466
- Locations
- 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
The Efficacy of Hand Narrow-Band Ultraviolet B (NBUVB) Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands
- Conditions
- Vitiligo
- Interventions
- Device: Monochromacitc Excimer lightDevice: NBUVB
- First Posted Date
- 2008-02-22
- Last Posted Date
- 2019-11-05
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 13
- Registration Number
- NCT00622180
- Locations
- 🇺🇸
UT Southwestern Medical Center at Dallas - Dermatology Clinical Trials, Dallas, Texas, United States
Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder
- Conditions
- Severe AsthmaModerate or Severe Major Depressive Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-02-22
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 26
- Registration Number
- NCT00621946
- Locations
- 🇺🇸
The UT Southwestern Medical Center at Dallas, Dallas, Texas, United States
Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma
- Conditions
- Lymphoproliferative DisorderSmall Intestine CancerBrain and Central Nervous System TumorsLymphoma
- Interventions
- Biological: autologous immunoglobulin idiotype-KLH conjugate vaccineBiological: sargramostimRadiation: radiation therapy
- First Posted Date
- 2008-02-22
- Last Posted Date
- 2018-11-26
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Registration Number
- NCT00621036
- Locations
- 🇺🇸
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas, Texas, United States